Theralink
About
News & Media
Biopharmas
Investor Relations
Contacts

Theralink’s Quarterly Newsletter

Theralink → Theralink’s Quarterly Newsletter

Theralink’s Quarterly Newsletter

Theralink’s Quarterly Newsletter

Coming Soon

Search for:

Recent Posts

Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium
Theralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U.S.
Theralink® Technologies Receives Final Medicare Reimbursement Rate Determination and PTAN Enrollment
Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer
Theralink® Technologies to Host Fireside Chat with Dr. Mick Ruxin on June 22nd at 11:00 a.m. ET

Menu

About
Investors
Contact
Privacy Policy

OUR SERVICES

Biopharmas
Oncologists
Media Room

Press Releases

Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium
Theralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U.S.
Theralink® Technologies Receives Final Medicare Reimbursement Rate Determination and PTAN Enrollment

Copyright © 2022 Theralink. All rights reserved.